Active material: Erythromycin, Zinc acetate
When ATH: D10AF52
CCF: Drug with antibacterial and komedonoliticheskim action for the treatment of acne
ICD-10 codes (testimony): L70
When CSF: 06.07.02
Manufacturer: ASTELLAS PHARMA EUROPE B.V. (Netherlands)
◊ Powder for solution for outdoor applications; приложенный растворитель – бесцветный, clear.
| 1 fl. | 1 ml ready-r-ra | |
| Erythromycin | 1.2 g | 40 mg |
| zinc acetate dihydrate | 360 mg | 12 mg |
Solvent: diizopropilsebaktat, ethanol.
Plastic Bottles (1) together with the solvent (fl. 30 ml 1 PC.) и аппликатором – пачки картонные.
Erythromycin-zinc complex. Anti-inflammatory, antibacterial action and komedonoliticheskoe.
Erythromycin bacteriostatic effect on microorganisms, causing acne: Propionibacterium acnes Staphylococcus epidermidis и. Zinc reduces the production of sebum, anti-inflammatory effect, to avoid the development of resistance to erythromycin.
Integrated communications components of the drug provides a good penetration into the skin of active substances.
Zinc is mainly associated with follicular epithelium and not resorbed into the systemic circulation.
A minor part of erythromycin exposed systemic absorption and further removed from the body.
- Acne treatment.
The drug is used topically. Using the supplied applicator prepared solution zinerita® put a thin layer on the affected area of the skin 2 times / day: morning (before applying make-up) and in the evening (after washing). Apply the drug should be by tilting the vial with the prepared solution down, with light pressure. The deposition rate of the solution is regulated pressure force applicator on the skin. Примерная разовая доза – 0.5 ml. After drying, the solution becomes invisible.
Course duration - 10-12 weeks. In some cases, clinical improvement occurs within 2 of the week.
Local reactions: it may sometimes be a burning sensation, irritation, dry skin at the site of drug. Usually, these effects are mild and do not require discontinuation of the drug and / or symptomatic therapy.
- Hypersensitivity to erythromycin and other macrolides;
- Hypersensitivity to zinc or other ingredients.
It is now established, that the use of the drug during pregnancy and lactation is possible if indicated in recommended doses.
In applying the drug should take into account the possibility of cross-resistance to other macrolide antibiotics, lincomycin, clindamycin.
Avoid contact with the eyes or mucous membrane of the mouth and nose, tk. it can cause irritation and burns.
Accidental overdose is unlikely due to the nature of local drug application.
To date, no clinically significant interaction found zinerita® with other drugs.
The drug is resolved to application as an agent Valium holidays.
The drug should be stored out of reach of children at temperature from 15 ° to 25 ° C. Cрок годности – 3 year.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More